{
  "schema_version": "0.1.0",
  "case_id": "HR-ET019",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ET019",
    "display_name": "Madam C. J. Walker",
    "aliases": [
      "Sarah Breedlove"
    ],
    "name_parts": {
      "given": [
        "Sarah"
      ],
      "family": "Walker"
    },
    "sex": "female",
    "era": "Early 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1867-12-23",
          "display": "December 23, 1867",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1867",
              "display": "1867",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0009"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Indiana Historical Society, 64 Parishes and the National Women's History Museum."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1919-05-25",
          "display": "May 25, 1919",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1919",
              "display": "1919",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0009"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited biographies."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ET019-SYN",
      "ssn": "000-19-7062",
      "date_of_birth": "1976-12-23",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Harriet Okonjo-Bell, MD",
      "fictional_consultant": {
        "name": "Desmond Achterberg, MD",
        "specialty": "Nephrology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1867-12-23",
        "display": "December 23, 1867",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born Sarah Breedlove in Delta, Louisiana, to formerly enslaved parents.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1875",
        "display": "by 1875",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Both parents had died by the time she was seven.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1904",
        "display": "1904",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Hair loss and scalp disease; began selling hair-care products as an agent.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1906-01-04",
        "display": "January 4, 1906",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Married Charles Joseph Walker in Denver and began her own company as Madam C. J. Walker.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1910",
        "display": "1910",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Company moved to Indianapolis; thousands of agents trained.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1916",
        "display": "1916",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Rest cure at Hot Springs, Arkansas, for her health; high blood pressure.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1917-07",
        "display": "July 1917",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Joined the committee of the Negro Silent Protest Parade petitioning for a federal law against lynching.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1917-11",
        "display": "mid-November 1917",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Nephritis worsened by hypertension diagnosed; rest at Battle Creek advised.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1919-04",
        "display": "April 1919",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Gravely ill in St. Louis; returned to New York.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1919-05-25",
        "display": "May 25, 1919",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died at Villa Lewaro, Irvington-on-Hudson, at 51.",
      "claim_ids": [
        "CLM-0009"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Madam C. J. Walker was born Sarah Breedlove on December 23, 1867, in Delta, Louisiana, the daughter of Owen and Minerva Anderson Breedlove. Both parents had been enslaved on a Madison Parish plantation, and she was their first child born into freedom.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "first child born into freedom"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0009",
          "relationship": "context",
          "locator": "roster birth year 1867"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "Both her parents had died by the time she was seven, and she went to live with an older sister and moved across the river to Vicksburg, Mississippi. She married Moses McWilliams at fourteen, had her only child, Lelia (later A'Lelia), and was widowed at twenty. She then moved to St. Louis, where she worked as a laundress and cook, sometimes for as little as a dollar a day.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors her early loss of both parents (cause not recorded) and the years of heavy physical work in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "While working as a laundress she began to lose her hair, a problem many Black women of her time shared. Her biographers attribute it to scalp disease such as dandruff, poor diet, a hard life and harsh washing products, in an era when most homes lacked indoor plumbing. In 1904 she began using and selling another Black woman's hair grower as a sales agent, then developed her own sulfur-containing ointments and shampoos to treat scalp disease.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; the origin of her products. The modern episode adds no scalp or hair diagnosis.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "inspired by her own hair loss; sulfur ointments for scalp disease"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "1904, sales agent"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "her scalp was balding in patches; poor nutrition, a hard life and harsh treatments"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In Denver she married Charles Joseph Walker, a newspaper advertising salesman (in January 1906, or 1905 in one account), and began calling herself Madam Walker, in part to avoid the familiar forms of address then used for Black women. She launched her own hair-care line there, set up headquarters and a training school for her agents in Pittsburgh in 1908, and moved the company to Indianapolis in 1910. She trained thousands of sales agents, \"hair culturists,\" who earned a share of the profits. She kept the name after the marriage ended.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors her chosen form of address and her work as a founder who trained agents and traveled constantly to sell and teach.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "1906 marriage, Madam C. J. Walker after the divorce"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "1905 marriage"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "January 4, 1906; Madame to avoid homier sobriquets; Pittsburgh 1908; agents shared profits"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Indianapolis 1910; several thousand agents"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "As her wealth grew she became a philanthropist and activist: she gave to the YWCA and paid tuition for students at Tuskegee Institute, and in 1915 she sued over discrimination at an Indianapolis theater.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors her philanthropy and civic work in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "philanthropy and activism grew with her wealth"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1915 lawsuit; Tuskegee"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "In 1917 she joined the committee of the Negro Silent Protest Parade in petitioning the President and Congress to make lynching a national crime. She gave $5,000 to the NAACP's anti-lynching work, and by her own report her company had more than twenty thousand agents by 1919.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the index date; anchors the later civic work and the size of her agent network.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "1917 petition"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "$5,000 to the NAACP"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "more than twenty thousand agents by 1919"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "The physical demands she placed on herself undermined her health, and she suffered from high blood pressure. She went for a rest cure at Hot Springs, Arkansas, in 1916, but otherwise did not slow her pace.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern hypertension. The teaching contrast: the historical advice was to rest and slow down; the modern plan treats the blood pressure and fits care around the work she chooses.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "suffered from hypertension; rest cure at Hot Springs in 1916; did not relax her pace"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "developed health problems, including high blood pressure and kidney failure"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "By mid-November 1917 a Chicago physician, Dr. George Sauer, diagnosed nephritis, an often irreversible inflammation of the kidneys made worse by her worsening hypertension, and advised an indefinite stay at the Battle Creek Sanitarium in Michigan, where she took a rest cure that year.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode. Anchors the modern kidney disease; the modern kidney findings are synthetic.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "chapter 17, as quoted"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "rest cure at Battle Creek Sanitarium in 1917"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "She moved into Villa Lewaro, her house at Irvington-on-Hudson, New York (in 1918; 1917 in one account). In April 1919 she became gravely ill in St. Louis and returned to New York.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "April 1919, St. Louis"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "very ill on a trip to St. Louis in April 1919"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "moved in 1917 to Villa Lewaro"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "She died on May 25, 1919, at Villa Lewaro, at 51. Accounts of the cause differ: chronic interstitial nephritis; kidney failure; or high blood pressure and kidney failure.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, two years after the modern episode. Anchors the hypertension and kidney disease.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "chronic interstitial nephritis"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "kidney failure"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "kidney failure, at 51"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "May 25, 1919, Villa Lewaro; high blood pressure and kidney failure"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "May 25, 1919"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports",
          "locator": "May 25, 1919, at Villa Lewaro"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Madam C.J. Walker (Famous Hoosiers)",
      "publisher": "Indiana Historical Society",
      "url": "https://indianahistory.org/education/educator-resources/famous-hoosiers/madam-c-j-walker/",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Historical society biography; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Jeansonne G, Luhrssen D. Madam C. J. Walker",
      "publisher": "64 Parishes (Louisiana Endowment for the Humanities)",
      "url": "https://64parishes.org/entry/madam-c-j-walker",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "McNatt M. Madam C. J. Walker's Rags to Riches Story Found in the Holdings of the National Archives",
      "publisher": "U.S. National Archives (The Text Message blog)",
      "url": "https://prologue.blogs.archives.gov/2021/07/22/madam-c-j-walkers-rags-to-riches-story-found-in-the-holdings-of-the-national-archives/",
      "source_type": "government",
      "published": "2021-07-22",
      "accessed": "2026-11-04",
      "rights_note": "Archives post on census and petition records; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Madam C.J. Walker (biography)",
      "publisher": "National Women's History Museum",
      "url": "https://www.womenshistory.org/education-resources/biographies/madam-cj-walker",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Museum biography; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Walker, Madame C.J. (1867-1919), Women in World History: A Biographical Encyclopedia",
      "publisher": "Gale, via Encyclopedia.com",
      "url": "https://encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/walker-madame-cj-1867-1919",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Reference encyclopedia drawing on A'Lelia Bundles's biographies; facts used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Madam Walker",
      "publisher": "Lemelson Center for the Study of Invention and Innovation",
      "url": "https://lemelson.mit.edu/resources/madam-walker",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "University inventor biography; facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "Bundles A. On Her Own Ground: The Life and Times of Madam C. J. Walker (Scribner, 2001), chapter 17, as quoted in the Wikipedia article on her",
      "publisher": "Wikipedia (quoting the Scribner biography)",
      "url": "https://en.wikipedia.org/wiki/Madam_C._J._Walker",
      "source_type": "biography",
      "published": "2001",
      "accessed": "2026-11-04",
      "rights_note": "The biography itself was not available; the quoted passage is used for the November 1917 diagnosis only, with the Gale entry for the Battle Creek stay."
    },
    {
      "source_id": "SRC-0008",
      "title": "Bundles A. The Centennial of Madam C. J. Walker's Death, May 25, 1919",
      "publisher": "A'Lelia Bundles (author's site)",
      "url": "https://aleliabundles.com/2019/05/",
      "source_type": "biography",
      "published": "2019-05",
      "accessed": "2026-11-04",
      "rights_note": "Biographer's post; used for the birth, the date and place of death and the funeral at Villa Lewaro."
    },
    {
      "source_id": "SRC-0009",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-02-09",
    "index_age": 49,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Hypertension with chronic kidney disease in a 49-year-old Black woman who founded and runs a national hair-care company and travels most weeks to train her sales agents. The episode covers accurate office measurement and 24-hour ambulatory and home monitoring under the 2025 AHA/ACC guideline; kidney function by the race-free CKD-EPI 2021 equation, stated explicitly, with the urine albumin-to-creatinine ratio, chronicity and KDIGO 2024 staging and risk; an angiotensin receptor blocker titrated to the maximum dose, an SGLT2 inhibitor for CKD with albuminuria, and a calcium channel blocker to reach goal; a statin chosen by shared decision; potassium and creatinine after each start or increase; sick-day rules tested by a real gastroenteritis; sodium counseling built on the food she likes; nephrology consultation; and a work and rest plan she sets herself. The teaching contrast is the historical advice to rest and slow down: here the risks are stated plainly, the treatment does the work, and she decides how she lives. Race and medicine: the eGFR uses no race term, the first medicine is chosen for the albuminuria rather than for her race, and APOL1 genetic testing is offered with counseling and left to her choice.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-02-09",
        "purpose": "Establishing care for high blood pressure found at a workplace screening, morning headaches and protein in the urine at last year's executive physical, in a company founder who travels most weeks"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-02-23",
        "purpose": "Two-week review of the 24-hour ambulatory blood pressure and the repeat kidney tests, with a kidney ultrasound and a nephrology consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-03-09",
        "purpose": "Two-week check of potassium and creatinine after starting losartan and empagliflozin, home readings, and the echocardiogram"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-04-13",
        "purpose": "Same-day sick visit for vomiting and diarrhea after a sales convention"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-04-27",
        "purpose": "Eleven-week review: home readings on maximum losartan, urine albumin, kidney function after a recent gastroenteritis, lipids on atorvastatin"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-06-08",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-08-17",
        "purpose": "Six-month review: blood pressure at goal, urine albumin, kidney function, hemoglobin, mood, and the travel season ahead"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Elevated blood pressure at intake (166/102 mmHg, average of two readings), first found at a workplace screening; ambulatory monitoring to confirm",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R03.0",
            "display": "Elevated blood-pressure reading, without diagnosis of hypertension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-02-23"
      },
      {
        "id": "PRB-002",
        "display": "Albumin in the urine (urine albumin-to-creatinine ratio 286 mg/g) with eGFR 54 by the race-free CKD-EPI 2021 equation; she recalls protein in the urine at an executive physical a year ago, and those records are requested; to be repeated and investigated",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R80.9",
            "display": "Proteinuria, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-02-23"
      },
      {
        "id": "PRB-003",
        "display": "Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (24-hour mean 149/94, daytime 154/98, night 140/88 without the normal nighttime fall), with left ventricular hypertrophy on ECG and mild hypertensive retinopathy; synthetic modern episode linked to her documented high blood pressure",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I12.9",
            "display": "Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern diagnosis anchored to the documented hypertension and nephritis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-02-23"
      },
      {
        "id": "PRB-004",
        "display": "Chronic kidney disease G3a A2 (eGFR 54 to 55 mL/min/1.73 m2 by the race-free CKD-EPI 2021 equation; albumin-to-creatinine ratio 286 to 294 mg/g; present for more than three months), most likely hypertensive kidney disease; bland urine sediment and normal-sized kidneys on ultrasound; 5-year kidney failure risk 1.6%",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "N18.31",
            "display": "Chronic kidney disease, stage 3a",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic kidney findings anchored to the documented nephritis and death from kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-02-23"
      },
      {
        "id": "PRB-005",
        "display": "Hyperlipidemia: LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations (intermediate)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E78.5",
            "display": "Hyperlipidemia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic laboratory finding.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-006",
        "display": "Viral gastroenteritis after a sales convention, with mild volume depletion and losartan and empagliflozin held under her sick-day rules; no acute kidney injury; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "A08.4",
            "display": "Viral intestinal infection, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intercurrent illness; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-13",
        "abatement_date": "2026-04-27"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Losartan 50 mg oral tablet, one tablet each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979492",
            "display": "losartan potassium 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet each morning, at the same home time when traveling"
        },
        "start_date": "2026-02-23",
        "end_date": "2026-03-09",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic angiotensin receptor blocker for hypertension with albuminuric CKD; chosen over an ACE inhibitor because a cough would interfere with her speaking.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Losartan 100 mg oral tablet, one tablet each morning",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "979480",
            "display": "losartan potassium 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet each morning"
        },
        "start_date": "2026-03-09",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic increase to the maximum dose for albuminuria and blood pressure above goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgery",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1545658",
            "display": "empagliflozin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet each morning, with sick-day rules"
        },
        "start_date": "2026-02-23",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic SGLT2 inhibitor for CKD with eGFR 20 or higher and albuminuria, without diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Atorvastatin 20 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617310",
            "display": "atorvastatin 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-02-23",
        "indication_problem_ids": [
          "PRB-005",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic moderate-intensity statin chosen with her after a risk discussion: intermediate 10-year risk with CKD as a risk enhancer.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Ondansetron 4 mg orally disintegrating tablet, one tablet on the tongue every 8 hours as needed for nausea, for up to two days",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "104894",
            "display": "ondansetron 4 MG Disintegrating Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "Every 8 hours as needed for nausea, up to two days"
        },
        "start_date": "2026-04-13",
        "end_date": "2026-04-15",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antiemetic so that she can drink enough to rehydrate by mouth.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Amlodipine 5 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197361",
            "display": "amlodipine 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic calcium channel blocker added because home readings stayed above goal on the maximum losartan dose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 4.4,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V1",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 25,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 1.22,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 54,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic eGFR by the race-free CKD-EPI 2021 equation; moderately decreased (G3a).",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 286,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio; moderately increased (A2), to be repeated.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 5.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c; no diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 250,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 174,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129,
          "text": "Below 130 mg/dL; lower on treatment by at least 30%"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 46,
        "unit": "mg/dL",
        "reference_range": {
          "low": 50
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 150,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 12.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH at the diagnosis of high blood pressure; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-09",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; minimal symptoms. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V2",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 294,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat urine albumin-to-creatinine ratio, confirming moderately increased albuminuria.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 1.21,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat creatinine; stable, and similar to a result from a year ago.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 55,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR (CKD-EPI 2021, race-free); G3a confirmed.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V2",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 9.4,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline mineral and bone tests for CKD G3a; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHOS-V2",
        "display": "Phosphate [Mass/volume] in Serum or Plasma",
        "label": "Phosphate",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 3.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 2.5,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2777-1",
            "display": "Phosphate [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline mineral and bone tests for CKD G3a; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-PTH-V2",
        "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
        "label": "Parathyroid hormone (intact)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 58,
        "unit": "pg/mL",
        "reference_range": {
          "low": 15,
          "high": 65
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2731-8",
            "display": "Parathyrin.intact [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline mineral and bone tests for CKD G3a; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-VITD-V2",
        "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
        "label": "25-hydroxyvitamin D",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-23",
        "value": 31,
        "unit": "ng/mL",
        "reference_range": {
          "low": 30,
          "high": 100
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "62292-8",
            "display": "25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline mineral and bone tests for CKD G3a; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V3",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan and empagliflozin; the expected small rise in creatinine.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V3",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan and empagliflozin; the expected small rise in creatinine.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V3",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 24,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan and empagliflozin; the expected small rise in creatinine.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 1.29,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting losartan and empagliflozin; the expected small rise in creatinine.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 51,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; a dip of under 10%, expected after starting these medicines.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V6",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel during vomiting and diarrhea, with losartan and empagliflozin held; mild volume depletion without acute kidney injury.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V6",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 4.9,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel during vomiting and diarrhea, with losartan and empagliflozin held; mild volume depletion without acute kidney injury.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V6",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 21,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "L",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel during vomiting and diarrhea, with losartan and empagliflozin held; mild volume depletion without acute kidney injury.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V6",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 1.46,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel during vomiting and diarrhea, with losartan and empagliflozin held; mild volume depletion without acute kidney injury.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V6",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 88,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel during vomiting and diarrhea, with losartan and empagliflozin held; mild volume depletion without acute kidney injury.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V6",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 44,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR while volume depleted.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; creatinine back to its on-treatment level after the gastroenteritis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 4.7,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; creatinine back to its on-treatment level after the gastroenteritis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V4",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 24,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; creatinine back to its on-treatment level after the gastroenteritis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 1.31,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; creatinine back to its on-treatment level after the gastroenteritis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 50,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; stable on treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V4",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 176,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio after two months of losartan and empagliflozin; 39% lower.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V4",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 172,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel nine weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V4",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 98,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129,
          "text": "Below 130 mg/dL; lower on treatment by at least 30%"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel nine weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V4",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 48,
        "unit": "mg/dL",
        "reference_range": {
          "low": 50
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel nine weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V4",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 130,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel nine weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ALT on atorvastatin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 4.8,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CO2-V5",
        "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
        "label": "Bicarbonate (total CO2)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 25,
        "unit": "mmol/L",
        "reference_range": {
          "low": 22,
          "high": 29
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2028-9",
            "display": "Carbon dioxide, total [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 1.3,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, race-free)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 50,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V5",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 128,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio; 56% below baseline, still moderately increased.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-17",
        "value": 12.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly hemoglobin for CKD G3; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-17",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; minimal symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V7",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-06-08",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V7",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-06-08",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen, below the risk threshold for women.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Twelve-lead electrocardiogram",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-09",
          "end": "2026-02-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic baseline ECG for high blood pressure: sinus rhythm, left ventricular hypertrophy by voltage criteria without strain (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "24-hour ambulatory blood pressure monitoring on a day at home, with readings every 20 minutes by day and every 30 minutes by night",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "164783007",
            "display": "Ambulatory blood pressure recording",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-10",
          "end": "2026-02-11"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic ambulatory monitoring to confirm the diagnosis; 24-hour mean 149/94, daytime 154/98, night 140/88, without the normal nighttime fall (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Ultrasound of both kidneys and the bladder",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1334074007",
            "display": "Ultrasonography of bilateral kidneys and bladder",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-23",
          "end": "2026-02-23"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic ultrasound: right kidney 10.4 cm and left 10.6 cm with normal cortical thickness and mildly increased echogenicity, no hydronephrosis, stones or cysts (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Transthoracic echocardiogram",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "40701008",
            "display": "Echocardiography",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-09",
          "end": "2026-03-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic echocardiogram for left ventricular hypertrophy on ECG: mild concentric hypertrophy, ejection fraction 60%, normal valves (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-06-08",
          "end": "2026-06-08"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Screening mammogram, both breasts",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "24623002",
            "display": "Screening mammography",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-06-22",
          "end": "2026-06-22"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic screening mammogram; no abnormality (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, inactivated, this season",
        "status": "completed",
        "date": "2026-02-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination; she had not had one this season.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-06-08",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose for an adult with chronic kidney disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)",
        "status": "completed",
        "date": "2026-06-08",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Tdap; no booster recorded within ten years.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-06-08",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination; recommended for adults 19 to 59 and for CKD, and her screening tests showed no immunity.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 2 of 2",
        "status": "completed",
        "date": "2026-08-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose, at least four weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "MTH",
          "display": "mother"
        },
        "condition": "Died when she was a young child; cause not recorded in the cited source",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "FH-002",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FTH",
          "display": "father"
        },
        "condition": "Died when she was a young child; cause not recorded in the cited source",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Hair loss and scalp disease in her thirties, while working as a laundress; resolved",
        "historical_date": {
          "iso": "1904",
          "display": "1904",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "High blood pressure, for which she took a rest cure at Hot Springs, Arkansas, the year before this visit; no treatment recorded",
        "historical_date": {
          "iso": "1916",
          "display": "1916",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing care for high blood pressure found at a workplace screening, morning headaches and protein in the urine at last year's executive physical, in a company founder who travels most weeks",
        "status": "finished",
        "date": "2026-02-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review of the 24-hour ambulatory blood pressure and the repeat kidney tests, with a kidney ultrasound and a nephrology consultation",
        "status": "finished",
        "date": "2026-02-23",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Two-week review of the 24-hour ambulatory blood pressure and the repeat kidney tests, with a kidney ultrasound and a nephrology consultation",
          "hpi": {
            "narrative": "Madam Walker returns two weeks after her first visit. She wore the ambulatory monitor for 24 hours on a day at home and has taken home readings morning and evening since, including on a three-day trip; the home average is 152/96. Her morning headaches continue on some days. She has taken no ibuprofen or naproxen. Her office sent the results of last year's executive physical: creatinine 1.18 mg/dL and protein 1+ on a urine dipstick, with no albumin test. She had the kidney ultrasound this morning and then met Dr. Achterberg of nephrology here. She has read about kidney disease and asked directly whether she is heading for dialysis, and what it would take to avoid it without giving up her travel.",
            "elements": [
              {
                "label": "Ambulatory monitoring",
                "value": "24-hour mean 149/94; daytime 154/98; night 140/88"
              },
              {
                "label": "Home blood pressure",
                "value": "Average 152/96 over seven days, travel days included"
              },
              {
                "label": "Earlier results",
                "value": "Creatinine 1.18 mg/dL and dipstick protein 1+ about a year ago"
              },
              {
                "label": "Kidney ultrasound",
                "value": "This morning"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or weight loss"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Morning headaches on some days; no weakness or vision loss"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or ankle swelling"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No blood in the urine; gets up once at night to pass urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain or rash"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 160/100 (average of two readings), pulse 80; weight 78.6 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; sustained apex beat; no murmur or bruit; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "Ambulatory 24-hour mean 149/94 and daytime 154/98, with home readings 152/96 and clinic 160/100: stage 2 hypertension confirmed, without white-coat effect. Blood pressure falls by only 9% at night (a non-dipping pattern, common in kidney disease). Target-organ damage: left ventricular hypertrophy on the intake ECG, mild hypertensive retinopathy and albuminuria. TSH and A1c normal. Because she has CKD with albuminuria, a medicine that blocks the renin-angiotensin system comes first, whatever her race; she chose losartan over an ACE inhibitor because a cough would interfere with her speaking",
              "plan": [
                "Losartan 50 mg each morning at a fixed home time",
                "Potassium and creatinine in two weeks; increase to 100 mg then if they allow",
                "Goal below 130/80, lower toward 120 systolic if she feels well",
                "Echocardiogram at the next visit for the hypertrophy on ECG"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3a A2",
              "assessment": "Repeat albumin-to-creatinine ratio 294 mg/g and creatinine 1.21 mg/dL (eGFR 55 by the race-free CKD-EPI 2021 equation). With protein on a dipstick and a similar creatinine a year ago, the abnormality has lasted more than three months, so this is chronic kidney disease, G3a A2: high risk on the KDIGO heat map. The equation used until recently, with a race coefficient, would have reported her eGFR as about 60 and could have delayed this diagnosis. Ultrasound: kidneys 10.4 and 10.6 cm, normal cortex, mildly increased echogenicity, no obstruction or stones. Urinalysis at intake showed 1+ protein without blood and a bland sediment. Calcium 9.4 mg/dL, phosphate 3.6 mg/dL, parathyroid hormone 58 pg/mL and 25-hydroxyvitamin D 31 ng/mL are normal. 5-year kidney failure risk 1.6% (KFRE): low, and she was told so plainly. Dr. Achterberg judges hypertensive kidney disease most likely",
              "plan": [
                "Empagliflozin 10 mg each morning",
                "Sick-day rules for losartan and empagliflozin written on a card for her bag",
                "Hepatitis B, hepatitis C and HIV tests today, as Dr. Achterberg advised",
                "APOL1 genetic testing explained; she will decide after reading about it",
                "Urine albumin again in about three months"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Hyperlipidemia",
              "assessment": "LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations, intermediate, with CKD as a risk enhancer. KDIGO advises a statin for adults with CKD from 50, or younger at higher risk; the ACC/AHA guideline favors one at intermediate risk with a risk enhancer. After reviewing the numbers she chose to start",
              "plan": [
                "Atorvastatin 20 mg daily",
                "Lipid panel and ALT in four to twelve weeks"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Office blood pressure (seated, five minutes' rest, validated device, correct cuff, average of two readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "160/100",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "24-hour ambulatory blood pressure monitoring",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "24-hour mean 149/94, daytime 154/98, night 140/88; non-dipping",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home blood pressure readings",
              "cadence": "Two readings morning and evening for seven days to confirm and after each change; then twice a week, travel days included",
              "status": "completed_today",
              "detail": "Seven-day average 152/96",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "78.6 kg, BMI 29.6",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, bicarbonate, creatinine and eGFR (CKD-EPI 2021, race-free)",
              "cadence": "Two to four weeks after starting or increasing losartan or empagliflozin; then every six months",
              "status": "completed_today",
              "detail": "Creatinine 1.21 mg/dL, eGFR 55 (CKD-EPI 2021, race-free); potassium 4.4 mmol/L two weeks ago; panel booked in two weeks after starting losartan and empagliflozin",
              "observation_ids": [
                "OBS-CR-V2",
                "OBS-EGFR-V2"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CKDEPI-2021",
                "GL-NKF-ASN-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Repeat to confirm; about three months after a treatment change; then every six months for G3a A2",
              "status": "completed_today",
              "detail": "294 mg/g, confirming 286 at intake",
              "observation_ids": [
                "OBS-UACR-V2"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium, phosphate and parathyroid hormone",
              "cadence": "At diagnosis of G3a, then every 6 to 12 months",
              "status": "completed_today",
              "detail": "Calcium 9.4, phosphate 3.6 mg/dL; parathyroid hormone 58 pg/mL",
              "observation_ids": [
                "OBS-CA-V2",
                "OBS-PHOS-V2",
                "OBS-PTH-V2"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "25-hydroxyvitamin D",
              "cadence": "At baseline",
              "status": "completed_today",
              "detail": "31 ng/mL",
              "observation_ids": [
                "OBS-VITD-V2"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urinalysis with microscopy",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "At intake: 1+ protein, no blood, bland sediment",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Kidney ultrasound",
              "cadence": "Once, at the diagnosis of CKD",
              "status": "completed_today",
              "detail": "Normal-sized kidneys, mildly increased echogenicity, no obstruction",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "Yearly in CKD G3",
              "status": "up_to_date",
              "detail": "12.4 g/dL at intake",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Kidney failure risk equation (4-variable), 2- and 5-year",
              "cadence": "Yearly for G3 to G5",
              "status": "completed_today",
              "detail": "5-year risk 1.6%, 2-year risk under 1%",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "10-year ASCVD risk (Pooled Cohort Equations)",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "7.9%, intermediate; CKD a risk enhancer",
              "guideline_ids": [
                "GL-ACC-CHOL-2018",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel and ALT",
              "cadence": "4 to 12 weeks after starting a statin, then yearly",
              "status": "up_to_date",
              "detail": "LDL 174 mg/dL at intake; atorvastatin started today",
              "guideline_ids": [
                "GL-ACC-CHOL-2018",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Baseline ECG, TSH and A1c",
              "cadence": "At the diagnosis of hypertension",
              "status": "up_to_date",
              "detail": "Done at intake: LVH by voltage; TSH 1.9; A1c 5.4%",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "At diagnosis of stage 2 hypertension or LVH on ECG",
              "status": "ordered",
              "detail": "Booked for the next visit",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Fundus examination",
              "cadence": "Yearly",
              "status": "up_to_date",
              "detail": "At intake: mild arteriolar narrowing, no hemorrhages",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety and reconciliation: no NSAIDs, sick-day rules, dizziness, ankle swelling, genital infection, cough, adherence across time zones",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No NSAIDs; sick-day card given; losartan, empagliflozin and atorvastatin explained, including genital hygiene on empagliflozin",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sodium and diet counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Video session with the dietitian booked before her next trip",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "referral",
              "measure": "Nephrology review",
              "cadence": "At diagnosis; then about six months, by video if she prefers",
              "status": "completed_today",
              "detail": "Seen by Dr. Achterberg today",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Potassium and creatinine in two weeks with the echocardiogram. Home readings twice a day for a week after starting, then twice a week. Call for dizziness, fainting, vomiting or diarrhea (hold losartan and empagliflozin), or swelling of the lips or tongue",
          "guideline_ids": [
            "GL-AHA-HTN-2025",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-CKDEPI-2021",
            "GL-NKF-ASN-2021",
            "GL-ACC-CHOL-2018",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Two-week check of potassium and creatinine after starting losartan and empagliflozin, home readings, and the echocardiogram",
        "status": "finished",
        "date": "2026-03-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Two-week check of potassium and creatinine after starting losartan and empagliflozin, home readings, and the echocardiogram",
          "hpi": {
            "narrative": "Madam Walker returns two weeks after starting losartan 50 mg, empagliflozin 10 mg and atorvastatin 20 mg. She has taken them each morning at home time, including on a four-day trip. Her home readings average 144/90, down from 152/96. The morning headaches have stopped. She has had no dizziness, cough, genital itching or muscle aches, and urinates slightly more in the first hours after the empagliflozin. She had a video session with the dietitian and has made a salt-free version of her seasoning blend. Her hepatitis B, hepatitis C and HIV tests were negative, and she has no hepatitis B immunity. The echocardiogram was done this morning. She leaves next week for three weeks of conventions.",
            "elements": [
              {
                "label": "Home blood pressure",
                "value": "Average 144/90 on losartan 50 mg"
              },
              {
                "label": "Side effects",
                "value": "None"
              },
              {
                "label": "Diet",
                "value": "Dietitian session done; salt-free seasoning blend"
              },
              {
                "label": "Screening tests",
                "value": "Hepatitis B and C and HIV negative; no hepatitis B immunity"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No dizziness or fainting"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "Morning headaches gone"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning or genital itching"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 148/92, pulse 78; weight 78.2 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3a A2",
              "assessment": "Potassium 4.6 mmol/L; creatinine 1.29 mg/dL (eGFR 51), up 7% from 1.21: the expected change after starting losartan and empagliflozin, well under the 30% that would call for review. Bicarbonate 24 mmol/L",
              "plan": [
                "Continue empagliflozin",
                "Increase losartan to 100 mg",
                "Potassium and creatinine two to four weeks after the increase"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "Improving but above goal. Echocardiogram: mild concentric left ventricular hypertrophy (septum 1.2 cm), ejection fraction 60%, normal valves; this should regress as her pressure comes down",
              "plan": [
                "Losartan 100 mg each morning",
                "Home readings daily for a week, then twice a week",
                "Amlodipine next if the average stays above 130/80"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Office blood pressure (seated, five minutes' rest, validated device, correct cuff, average of two readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "148/92",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home blood pressure readings",
              "cadence": "Two readings morning and evening for seven days to confirm and after each change; then twice a week, travel days included",
              "status": "completed_today",
              "detail": "Average 144/90",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "78.2 kg",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, bicarbonate, creatinine and eGFR (CKD-EPI 2021, race-free)",
              "cadence": "Two to four weeks after starting or increasing losartan or empagliflozin; then every six months",
              "status": "completed_today",
              "detail": "Two weeks after starting: potassium 4.6, bicarbonate 24 mmol/L; creatinine 1.29 mg/dL, eGFR 51, a 7% rise; repeat two to four weeks after today's increase",
              "observation_ids": [
                "OBS-NA-V3",
                "OBS-K-V3",
                "OBS-CO2-V3",
                "OBS-CR-V3",
                "OBS-EGFR-V3"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-KDIGO-BP-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Repeat to confirm; about three months after a treatment change; then every six months for G3a A2",
              "status": "up_to_date",
              "detail": "294 mg/g two weeks ago; next at about three months",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "At diagnosis of stage 2 hypertension or LVH on ECG",
              "status": "completed_today",
              "detail": "Mild concentric LVH; ejection fraction 60%",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel and ALT",
              "cadence": "4 to 12 weeks after starting a statin, then yearly",
              "status": "up_to_date",
              "detail": "Atorvastatin started two weeks ago; panel at the next visit",
              "guideline_ids": [
                "GL-ACC-CHOL-2018",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety and reconciliation: no NSAIDs, sick-day rules, dizziness, ankle swelling, genital infection, cough, adherence across time zones",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No dizziness, cough, genital itching or muscle aches; doses taken at home time when traveling; sick-day card in her bag",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sodium and diet counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Dietitian session done; salt-free seasoning; ordering strategies for banquets",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV tests",
              "cadence": "Once, with the kidney evaluation",
              "status": "completed_today",
              "detail": "All negative; no hepatitis B immunity, so vaccination is planned",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            }
          ],
          "follow_up": "Potassium and creatinine two to four weeks after the losartan increase. Review in about seven weeks with the urine albumin, kidney function and lipids. Call for dizziness, fainting, or vomiting or diarrhea (hold losartan and empagliflozin)",
          "guideline_ids": [
            "GL-AHA-HTN-2025",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-ACC-CHOL-2018",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Eleven-week review: home readings on maximum losartan, urine albumin, kidney function after a recent gastroenteritis, lipids on atorvastatin",
        "status": "finished",
        "date": "2026-04-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Eleven-week review: home readings on maximum losartan, urine albumin, kidney function after a recent gastroenteritis, lipids on atorvastatin",
          "hpi": {
            "narrative": "Madam Walker returns two weeks after her sick visit for gastroenteritis. The vomiting and diarrhea settled within two days, and she restarted losartan and empagliflozin once she had eaten normally for a day. The potassium and creatinine check due two to four weeks after the losartan increase was not done: she was on a three-week convention tour and her office had booked no laboratory day. The panel planned for the week after the sick visit was also missed when she left on another trip. Her home readings on losartan 100 mg average 134/84. She has had no dizziness, cough, genital itching or muscle aches. She is asking for sauces on the side and no added salt at banquets.",
            "elements": [
              {
                "label": "Home blood pressure",
                "value": "Average 134/84 on losartan 100 mg"
              },
              {
                "label": "Missed checks",
                "value": "Panel after the losartan increase, and the panel a week after the gastroenteritis"
              },
              {
                "label": "Gastroenteritis",
                "value": "Resolved; losartan and empagliflozin restarted after a day of normal eating"
              },
              {
                "label": "Side effects",
                "value": "None"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No dizziness; weight back up by 0.8 kg since the illness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Bowels normal"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No ankle swelling"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning or genital itching"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 136/86, pulse 76; weight 77.2 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no ankle swelling"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "Above goal on the maximum losartan dose: home 134/84, clinic 136/86",
              "plan": [
                "Add amlodipine 5 mg daily",
                "Home readings daily for a week, then twice a week",
                "Watch for ankle swelling"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3a A2",
              "assessment": "Urine albumin-to-creatinine ratio 176 mg/g, 39% below the baseline of 286 to 294. Potassium 4.7 mmol/L; creatinine 1.31 mg/dL (eGFR 50), back from 1.46 during the gastroenteritis to its on-treatment level. Both missed checks caused no harm judging by the sick-visit panel and today's results",
              "plan": [
                "Continue losartan 100 mg and empagliflozin",
                "Her office will book every laboratory check on a home day before trips are scheduled",
                "Urine albumin and kidney function at six months"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Hyperlipidemia",
              "assessment": "LDL 98 mg/dL on atorvastatin 20 mg, 44% lower than 174; ALT 22 U/L; no muscle aches",
              "plan": [
                "Continue atorvastatin 20 mg; yearly lipid panel"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Viral gastroenteritis",
              "assessment": "Resolved; kidney function recovered",
              "plan": [
                "Sick-day rules reviewed again; they worked"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Office blood pressure (seated, five minutes' rest, validated device, correct cuff, average of two readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "136/86",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home blood pressure readings",
              "cadence": "Two readings morning and evening for seven days to confirm and after each change; then twice a week, travel days included",
              "status": "completed_today",
              "detail": "Average 134/84",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "77.2 kg",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, bicarbonate, creatinine and eGFR (CKD-EPI 2021, race-free)",
              "cadence": "Two to four weeks after starting or increasing losartan or empagliflozin; then every six months",
              "status": "deferred",
              "detail": "Missed: the panel due two to four weeks after the losartan increase was not done because she was on a three-week tour with no laboratory day booked, and the panel planned a week after the gastroenteritis was missed for another trip. No harm judging by the sick-visit panel (potassium 4.9 mmol/L, creatinine 1.46 mg/dL while volume depleted) and today's results (potassium 4.7 mmol/L, bicarbonate 24 mmol/L, creatinine 1.31 mg/dL, eGFR 50). Corrective action: her office books each laboratory check on a home day before trips are scheduled (INT-012)",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4",
                "OBS-CO2-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-KDIGO-BP-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Repeat to confirm; about three months after a treatment change; then every six months for G3a A2",
              "status": "completed_today",
              "detail": "176 mg/g, 39% lower",
              "observation_ids": [
                "OBS-UACR-V4"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel and ALT",
              "cadence": "4 to 12 weeks after starting a statin, then yearly",
              "status": "completed_today",
              "detail": "LDL 98, total cholesterol 172, HDL 48, triglycerides 130 mg/dL; ALT 22 U/L",
              "observation_ids": [
                "OBS-CHOL-V4",
                "OBS-LDL-V4",
                "OBS-HDL-V4",
                "OBS-TG-V4",
                "OBS-ALT-V4"
              ],
              "guideline_ids": [
                "GL-ACC-CHOL-2018",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety and reconciliation: no NSAIDs, sick-day rules, dizziness, ankle swelling, genital infection, cough, adherence across time zones",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sick-day rules applied correctly during the gastroenteritis; no side effects; amlodipine added",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sodium and diet counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sauces on the side and no added salt at banquets; water on travel days",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-KDIGO-CKD-2024"
              ]
            }
          ],
          "follow_up": "Preventive visit in about six weeks. Six-month review in the summer with urine albumin, kidney function and hemoglobin, booked on a home day. Call for ankle swelling, dizziness, or vomiting or diarrhea (hold losartan and empagliflozin)",
          "guideline_ids": [
            "GL-AHA-HTN-2025",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-ACC-CHOL-2018",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six-month review: blood pressure at goal, urine albumin, kidney function, hemoglobin, mood, and the travel season ahead",
        "status": "finished",
        "date": "2026-08-17",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Six-month review: blood pressure at goal, urine albumin, kidney function, hemoglobin, mood, and the travel season ahead",
          "hpi": {
            "narrative": "Madam Walker returns ten weeks after her preventive visit; the laboratory day was booked before her summer trips, as planned. Her home readings average 123/77 on losartan 100 mg, amlodipine 5 mg and empagliflozin 10 mg. She has had no ankle swelling, dizziness, genital itching or muscle aches. Her mammogram was normal and her HPV test and stool test were negative. Having read about APOL1 testing, she has decided not to have it for now, since it would not change her treatment; she knows it remains available. She plans an autumn of travel and asked what she should watch for on the road.",
            "elements": [
              {
                "label": "Home blood pressure",
                "value": "Average 123/77"
              },
              {
                "label": "Screening",
                "value": "Mammogram normal; HPV and stool tests negative"
              },
              {
                "label": "APOL1 testing",
                "value": "Declined for now, her choice"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 3"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No dizziness; weight down 3.2 kg since intake"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No ankle swelling or palpitations"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning or genital itching"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 122/76, pulse 72; weight 75.8 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "At goal: 122/76 in the clinic, 123/77 at home, on three medicines without side effects",
              "plan": [
                "Continue losartan 100 mg, amlodipine 5 mg and home readings twice a week on the road"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3a A2",
              "assessment": "Urine albumin-to-creatinine ratio 128 mg/g, 56% below baseline but still moderately increased. Potassium 4.8 mmol/L; creatinine 1.30 mg/dL, eGFR 50 (race-free CKD-EPI 2021), stable on treatment. Hemoglobin 12.6 g/dL. 5-year kidney failure risk 1.7%",
              "plan": [
                "Continue losartan and empagliflozin",
                "Urine albumin, kidney function and potassium every six months; calcium, phosphate and parathyroid hormone at one year",
                "Video review with Dr. Achterberg next month, as he planned"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Office blood pressure (seated, five minutes' rest, validated device, correct cuff, average of two readings)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "122/76",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Home blood pressure readings",
              "cadence": "Two readings morning and evening for seven days to confirm and after each change; then twice a week, travel days included",
              "status": "completed_today",
              "detail": "Average 123/77",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "75.8 kg, down 3.2 kg since intake",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, bicarbonate, creatinine and eGFR (CKD-EPI 2021, race-free)",
              "cadence": "Two to four weeks after starting or increasing losartan or empagliflozin; then every six months",
              "status": "completed_today",
              "detail": "Potassium 4.8, bicarbonate 25 mmol/L; creatinine 1.30 mg/dL, eGFR 50",
              "observation_ids": [
                "OBS-NA-V5",
                "OBS-K-V5",
                "OBS-CO2-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Repeat to confirm; about three months after a treatment change; then every six months for G3a A2",
              "status": "completed_today",
              "detail": "128 mg/g, 56% lower than baseline",
              "observation_ids": [
                "OBS-UACR-V5"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin",
              "cadence": "Yearly in CKD G3",
              "status": "completed_today",
              "detail": "12.6 g/dL",
              "observation_ids": [
                "OBS-HGB-V5"
              ],
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Calcium, phosphate and parathyroid hormone",
              "cadence": "At diagnosis of G3a, then every 6 to 12 months",
              "status": "due",
              "detail": "Normal at diagnosis; repeat at one year",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Kidney failure risk equation (4-variable), 2- and 5-year",
              "cadence": "Yearly for G3 to G5",
              "status": "completed_today",
              "detail": "5-year risk 1.7%",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel and ALT",
              "cadence": "4 to 12 weeks after starting a statin, then yearly",
              "status": "up_to_date",
              "detail": "LDL 98 mg/dL in April; yearly panel at one year",
              "guideline_ids": [
                "GL-ACC-CHOL-2018",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Fundus examination",
              "cadence": "Yearly",
              "status": "due",
              "detail": "Dilated examination by an optometrist booked for the autumn",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine safety and reconciliation: no NSAIDs, sick-day rules, dizziness, ankle swelling, genital infection, cough, adherence across time zones",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No ankle swelling, dizziness, genital itching or muscle aches; sick-day card current",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination review",
              "cadence": "Yearly in CKD",
              "status": "completed_today",
              "detail": "Hepatitis B dose 2 given today; influenza and COVID-19 due in the autumn; zoster from 50",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024",
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Sodium and diet counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Salt-free seasoning at home; restaurant choices on the road",
              "guideline_ids": [
                "GL-AHA-HTN-2025",
                "GL-KDIGO-CKD-2024"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At intake, then yearly",
              "status": "completed_today",
              "detail": "PHQ-9 3",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Nephrology review",
              "cadence": "At diagnosis; then about six months, by video if she prefers",
              "status": "due",
              "detail": "Video review with Dr. Achterberg booked for next month",
              "guideline_ids": [
                "GL-KDIGO-CKD-2024"
              ]
            }
          ],
          "follow_up": "Video review with nephrology next month. Influenza and COVID-19 vaccines in the autumn; zoster after her birthday. Review in six months with urine albumin, kidney function, the yearly lipid panel and calcium, phosphate and parathyroid hormone, booked on a home day. Hold losartan and empagliflozin on days of vomiting, diarrhea or not eating",
          "guideline_ids": [
            "GL-AHA-HTN-2025",
            "GL-KDIGO-CKD-2024",
            "GL-KDIGO-BP-2021",
            "GL-ACC-CHOL-2018",
            "GL-CMID-2026",
            "GL-USPSTF-DEP-2023",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for viral gastroenteritis with sick-day rules",
        "status": "finished",
        "date": "2026-04-13",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Vomiting and diarrhea since the day before yesterday",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Madam Walker called this morning and was seen the same day. She came home two days ago from a sales convention where several agents had a stomach illness. That night she began vomiting, four times by morning, with six loose watery stools over the next day and cramping around the navel. The vomiting stopped yesterday afternoon; she is keeping down sips of broth and an oral rehydration drink, and the diarrhea has slowed to two stools today. No blood in the stool and no fever above 37.5 °C. She feels light-headed when she stands quickly. Following the sick-day card in her bag, she has not taken losartan or empagliflozin since the vomiting began; she took nothing for pain. She has kept taking atorvastatin. She is passing less urine than usual.",
            "elements": [
              {
                "label": "Onset",
                "value": "Two nights ago, after a sales convention"
              },
              {
                "label": "Duration",
                "value": "About 36 hours"
              },
              {
                "label": "Character",
                "value": "Vomiting, watery diarrhea, crampy pain around the navel"
              },
              {
                "label": "Severity",
                "value": "Moderate; vomiting stopped; two stools today"
              },
              {
                "label": "Context",
                "value": "Stomach illness among agents at the convention; CKD G3a on losartan 100 mg and empagliflozin"
              },
              {
                "label": "Modifying factors",
                "value": "Losartan and empagliflozin held under her sick-day rules; rehydration drink"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Light-headed on standing; less urine; no blood in the stool, no high fever"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; temperature up to 37.5 °C at home"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Vomiting stopped; watery diarrhea slowing; crampy pain; no blood or black stool"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Passing less urine; no burning"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Light-headed on standing; no chest pain or palpitations"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion, weakness or severe headache"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but alert and talking easily; temperature 37.4 °C"
            },
            {
              "system": "Blood pressure lying and standing",
              "finding": "112/72 with pulse 96 lying; 102/66 with pulse 108 after two minutes standing, with light-headedness"
            },
            {
              "system": "Mouth",
              "finding": "Mucous membranes slightly dry"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; mild tenderness around the navel without guarding; active bowel sounds; no rebound"
            },
            {
              "system": "Skin",
              "finding": "Skin turgor slightly reduced; no rash"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-006",
              "display": "Viral gastroenteritis with mild volume depletion",
              "assessment": "Probable viral gastroenteritis, with similar illness among people she was with. Vomiting has stopped and she can drink. Mild volume depletion: postural rise in pulse, dry mouth, less urine. No blood in the stool, high fever or severe pain, so stool tests and antibiotics are not needed. Creatinine 1.46 mg/dL (eGFR 44), up from 1.29 on treatment: a rise of 0.17 mg/dL, below the threshold for acute kidney injury, from volume loss. Potassium 4.9 and bicarbonate 21 mmol/L, glucose 88 mg/dL",
              "plan": [
                "Oral rehydration solution, small amounts often, at least 2 to 3 liters a day until urine is pale",
                "Ondansetron 4 mg dissolved on the tongue every 8 hours as needed, for up to two days",
                "Bland food as she feels able",
                "Hand washing and separate towels at home"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Chronic kidney disease G3a A2, sick-day rules",
              "assessment": "She applied her sick-day rules correctly. With volume loss, losartan and empagliflozin can lower kidney blood flow further, and empagliflozin adds to fluid loss; holding both is right. Atorvastatin can continue",
              "plan": [
                "Keep holding losartan and empagliflozin until she has eaten and drunk normally for 24 hours, then restart both at the usual doses",
                "No ibuprofen or naproxen; acetaminophen if needed",
                "Metabolic panel within a week",
                "Go to the emergency department for vomiting that returns and stops her drinking, fainting, no urine for 12 hours, or blood in the stool"
              ]
            }
          ],
          "follow_up": "Nurse phone call tomorrow. Metabolic panel within a week; eleven-week review in two weeks as booked. Emergency care for vomiting that stops her drinking, fainting, no urine for 12 hours, or blood in the stool",
          "guideline_ids": [
            "GL-KDIGO-CKD-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the gastroenteritis is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-06-08",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed on the patient portal before the visit and reviewed with her by Dr. Okonjo-Bell",
          "hpi": {
            "narrative": "Madam Walker is a 49-year-old company founder with hypertension and chronic kidney disease G3a A2 who comes for her yearly preventive visit six weeks after her eleven-week review. Amlodipine was added then, and her home readings now average 127/80. She has had no ankle swelling, dizziness or genital itching. She restarted losartan and empagliflozin after the stomach illness two months ago and has had no further trouble. She has been on the road three weeks out of four, sleeping six hours on travel nights. She is using the salt-free seasoning at home and asking for sauces on the side at banquets. She wants to know which screening tests she needs and when, so that she can fit them between trips.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 49"
              },
              {
                "label": "Home blood pressure",
                "value": "Average 127/80 on losartan 100 mg and amlodipine 5 mg"
              },
              {
                "label": "Travel",
                "value": "Three weeks in four"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 0"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy and purposeful; stress from the pace of work, which she manages and does not want to give up"
            },
            {
              "domain": "Substance use",
              "finding": "No tobacco or drugs; a glass of wine at some events (AUDIT-C 1)"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks during layovers and on home mornings, about 120 minutes a week"
            },
            {
              "domain": "Nutrition",
              "finding": "Salt-free seasoning at home; sauces on the side and no added salt on the road; water in place of a third coffee"
            },
            {
              "domain": "Sleep",
              "finding": "Six hours on travel nights, seven at home"
            },
            {
              "domain": "Food and housing",
              "finding": "Secure"
            },
            {
              "domain": "Safety",
              "finding": "Seat belt always; feels safe at home"
            },
            {
              "domain": "Health care experiences",
              "finding": "Wants the numbers and the reasons; satisfied that her plan fits her work"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or weight change; weight down 2.4 kg since intake"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hoarseness"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Stomach illness resolved; no blood in the stool"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No burning, itching or discharge; periods becoming irregular"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump, skin change or nipple discharge"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No changing moles; no scalp or hair problems"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headaches since her blood pressure came down"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; PHQ-2 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 76.6 kg, BMI 28.8; blood pressure 126/80"
            },
            {
              "system": "Eyes",
              "finding": "Visual acuity 20/20 in each eye with reading glasses for near"
            },
            {
              "system": "Mouth",
              "finding": "Teeth and gums healthy"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no ankle swelling"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Breast",
              "finding": "Examined with a female chaperone and her agreement: no masses, skin changes or nipple discharge"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender"
            },
            {
              "system": "Skin",
              "finding": "No suspicious lesions"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged and direct"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. HIV, hepatitis C and hepatitis B screening were done with the kidney evaluation in February and were negative, without hepatitis B immunity. She chose a primary HPV test today for cervical screening, a stool immunochemical test kit she can mail from the road, and a mammogram in two weeks on a home day. Pneumococcal, Tdap and the first hepatitis B vaccines given with her agreement",
              "plan": [
                "Mammogram in two weeks",
                "Mail the stool test kit",
                "Second hepatitis B dose in about two months, at the six-month review",
                "Recombinant zoster vaccine from 50, after her birthday",
                "Influenza and COVID-19 vaccines in the autumn",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Hypertension with chronic kidney disease",
              "assessment": "At goal at home and in the clinic on losartan 100 mg and amlodipine 5 mg",
              "plan": [
                "Continue the current medicines and home readings twice a week, on the road too"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure",
              "status": "completed_today",
              "detail": "126/80 mmHg; home average 127/80",
              "guideline_ids": [
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C 1",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "ordered",
              "detail": "Mammogram every two years from 40; booked in two weeks on a day she is home",
              "guideline_ids": [
                "GL-USPSTF-BRCA-2024"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "completed_today",
              "detail": "Primary HPV test every five years from 30, her choice",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "From 45; stool immunochemical test yearly, her choice so that she can mail it while traveling; colonoscopy discussed",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "HIV screening",
              "status": "up_to_date",
              "detail": "Negative with the kidney evaluation in February",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "up_to_date",
              "detail": "Negative with the kidney evaluation in February",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening",
              "status": "up_to_date",
              "detail": "Surface antigen negative, no immunity, in February; vaccination started today",
              "guideline_ids": [
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "up_to_date",
              "detail": "A1c 5.4% at intake",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Statin for prevention",
              "status": "up_to_date",
              "detail": "Atorvastatin 20 mg since February; LDL 98 mg/dL",
              "guideline_ids": [
                "GL-ACC-CHOL-2018"
              ]
            },
            {
              "service": "Healthy diet and physical activity counseling",
              "status": "completed_today",
              "detail": "Sodium plan with the dietitian; walking during layovers",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 for chronic kidney disease",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tdap",
              "status": "completed_today",
              "detail": "No booster within ten years",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "completed_today",
              "detail": "Dose 1 of 2 (HepB-CpG)",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "due",
              "detail": "From 50, after her birthday",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Influenza and COVID-19 vaccines",
              "status": "due",
              "detail": "Influenza given in February; both due in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Eye examination",
              "status": "due",
              "detail": "Mild hypertensive retinopathy at intake; dilated examination by an optometrist yearly",
              "guideline_ids": [
                "GL-PREV-2026",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "service": "Osteoporosis screening",
              "status": "not_indicated",
              "detail": "Not yet postmenopausal and no risk factors that call for earlier screening",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with her consent. She wants full treatment of any illness that could be reversed, including dialysis if her kidneys ever failed, and wants to be told plainly what is happening at every stage. She has named a health care agent, recorded in the confidential part of the chart and not named here, and has a will and business succession plan in place through her company. She chose not to record other treatment preferences today. To be revisited yearly or after any serious illness.",
          "follow_up": "Mammogram in two weeks; stool test by mail; HPV result by the portal. Six-month review in ten weeks with urine albumin, kidney function, hemoglobin, the PHQ-9 and the second hepatitis B dose. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-USPSTF-BRCA-2024",
            "GL-USPSTF-CERV-2018",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-ALC-2018",
            "GL-CDC-HBV-2023",
            "GL-CDC-IMZ-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-02-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 79.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 29.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 166,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 102,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 82,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated upper-arm device and a correctly sized cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-02-23",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 78.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 29.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 160,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 100,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated upper-arm device and a correctly sized cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-03-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 78.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 29.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 148,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 92,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated upper-arm device and a correctly sized cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-04-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 77.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 29.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 136,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 86,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated upper-arm device and a correctly sized cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-08-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 75.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs, seated after five minutes' rest, average of two readings with a validated upper-arm device and a correctly sized cuff. No measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-04-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 76.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 96,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.4,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit, lying: a faster pulse and lower blood pressure with mild volume depletion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-06-08",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 163,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 76.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the preventive visit, seated, average of two readings.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Founder and chief executive of a hair-care and beauty company with a national network of independent sales agents, most of them Black women, whom she recruits and trains in person; travels most weeks to conventions, churches, schools and halls to teach and speak",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented company and agent network.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Gives to scholarships, schools, the YWCA and civil-rights organizations, and has gone to court against racial discrimination",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern civic life anchored to her documented philanthropy and activism.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Lives in the city in a house she owns, and is having a larger house built outside it; one adult daughter. Grew up in rural Louisiana and Mississippi and worked for years as a laundress before her business",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic household anchored to her documented early life and later houses; her daughter has no role in the episode.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Eats most meals on the road at banquets, receptions and restaurants; cooks on Sundays at home, the Louisiana dishes she grew up with; uses a salty seasoning blend and smoked meats for flavor; drinks a lot of coffee and too little water when traveling",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic diet history for the sodium plan; her real diet was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Tobacco: never. Alcohol: a glass of wine at some events, under one drink a week. No drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic entry for the modern episode; her real use was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Sleeps five to six hours on travel nights and seven at home; walks when she can between meetings; health insurance through her company",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic entry.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "SOC-007",
        "display": "Asks to be addressed as Madam Walker, the title she chose for herself",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic patient preference anchored to her documented choice of title.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all daily activities; works long days and travels most weeks; no limitation in walking or climbing stairs",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, direct, organized and quick; asks for the numbers and the reasons; mood steady; PHQ-9 score 4",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Albumin in the urine (286 mg/g) and an eGFR of 54 by the race-free CKD-EPI 2021 equation in a 49-year-old woman with high blood pressure readings awaiting ambulatory confirmation, left ventricular hypertrophy on ECG and protein on a dipstick a year ago. Please advise on the cause, any further tests, kidney-protective treatment and her blood pressure target, APOL1 testing, and a monitoring plan that fits a schedule of travel most weeks",
        "urgency": "Within two weeks, on the day of her two-week visit, so that she makes one trip",
        "pertinent_history": "She founded and runs a hair-care company with a national network of sales agents and travels most weeks to train and speak. A workplace screening found high blood pressure; she has had morning headaches for some months. Her office has requested last year's executive physical results, which she recalls showed protein in the urine. No diabetes, no NSAID use, no kidney stones, no known family kidney disease; both parents died when she was a child. Today: blood pressure 166/102 (average of two readings), pulse 82, weight 79.0 kg, BMI 29.7. Fundi: mild arteriolar narrowing without hemorrhages. Results today: sodium 140, potassium 4.4, bicarbonate 25 mmol/L; creatinine 1.22 mg/dL, eGFR 54 (CKD-EPI 2021, race-free); glucose 94 mg/dL; A1c 5.4%; urine albumin-to-creatinine ratio 286 mg/g; urinalysis 1+ protein, no blood, bland sediment; total cholesterol 250, LDL 174, HDL 46, triglycerides 150 mg/dL; hemoglobin 12.4 g/dL; TSH 1.9. ECG: sinus rhythm, left ventricular hypertrophy by voltage criteria. Planned before your visit: 24-hour ambulatory monitoring and home readings, a repeat urine albumin and creatinine, calcium, phosphate, parathyroid hormone and 25-hydroxyvitamin D, and a kidney ultrasound on the morning of your visit. No medicines started yet",
        "questions": [
          "Is this hypertensive kidney disease, or does she need tests for another cause, or a kidney biopsy?",
          "Which medicines do you advise for her blood pressure and kidneys, and what is her blood pressure target?",
          "Should she start an SGLT2 inhibitor without diabetes?",
          "Should she be offered APOL1 genetic testing, and how would the result be used?",
          "How should we monitor potassium, creatinine and albumin, given that she travels most weeks?",
          "What is her risk of kidney failure, and when should she see you again?"
        ]
      },
      "consultant_note": {
        "history": "Madam Walker, 49, is seen at the request of Dr. Okonjo-Bell on the day of her two-week visit. She asked to be addressed as Madam Walker. Her ambulatory monitor showed a 24-hour mean of 149/94, daytime 154/98 and night 140/88, and her home readings average 152/96. Her office has sent last year's executive physical: creatinine 1.18 mg/dL and protein 1+ on a dipstick. She has had morning headaches on some days. She has no visible blood in the urine, no foamy urine she has noticed, no swelling, rash, joint pain, mouth ulcers or kidney stones, and takes no NSAIDs, supplements or herbal products. No known family kidney disease; both parents died when she was a child. She asked plainly whether she will need dialysis and said she would take whatever medicines were needed but would not give up her travel",
        "data_reviewed": "Dr. Okonjo-Bell's intake note and results: creatinine 1.22 mg/dL, eGFR 54 at intake and 1.21 mg/dL, eGFR 55 today (CKD-EPI 2021, race-free); potassium 4.4 mmol/L; urine albumin-to-creatinine ratio 286 mg/g at intake and 294 mg/g today; urinalysis 1+ protein without blood, bland sediment; calcium 9.4 mg/dL, phosphate 3.6 mg/dL, parathyroid hormone 58 pg/mL, 25-hydroxyvitamin D 31 ng/mL; A1c 5.4%; LDL 174 mg/dL; hemoglobin 12.4 g/dL. ECG: left ventricular hypertrophy by voltage. Kidney ultrasound this morning: right kidney 10.4 cm, left 10.6 cm, normal cortical thickness, mildly increased echogenicity, no hydronephrosis, stones or cysts. Ambulatory and home readings as above; clinic 160/100 today",
        "exam": [
          {
            "system": "General",
            "finding": "Well, articulate and engaged"
          },
          {
            "system": "Vital signs",
            "finding": "Blood pressure 160/100 and pulse 80, measured by the clinic nurse today"
          },
          {
            "system": "Cardiovascular",
            "finding": "Regular rhythm; sustained apex beat; no bruits"
          },
          {
            "system": "Extremities",
            "finding": "No ankle swelling; no rash"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-004",
            "display": "Chronic kidney disease G3a A2",
            "assessment": "Albuminuria and a reduced eGFR present for more than a year: CKD G3a A2, high risk on the KDIGO heat map. Long-standing hypertension with left ventricular hypertrophy and retinopathy, a bland sediment without hematuria, albuminuria below 300 mg/g and normal-sized kidneys make hypertensive kidney disease the most likely cause. A primary glomerular disease is less likely, and a biopsy is not needed now. Her 5-year kidney failure risk is 1.6% (4-variable KFRE): low, and treatment can lower it further. The race-free equation stages her correctly; the older equation with a race coefficient would have reported an eGFR of about 60"
          },
          {
            "problem_id": "PRB-003",
            "display": "Hypertension with chronic kidney disease",
            "assessment": "Stage 2 hypertension confirmed by ambulatory monitoring, with a non-dipping pattern. With albuminuria, a renin-angiotensin blocker at the maximum tolerated dose is the foundation, chosen for the kidney disease and not for her race; an ARB avoids the cough of an ACE inhibitor, which matters for her work. Target below 130/80, and a systolic near 120 if she tolerates it with standardized measurement"
          }
        ],
        "recommendations": [
          "Losartan 50 mg each morning, increased to 100 mg after two weeks if potassium is below 5.5 mmol/L and creatinine has risen by less than 30%",
          "Empagliflozin 10 mg daily for kidney protection, indicated at her eGFR and albuminuria without diabetes; expect a small early dip in eGFR",
          "Sick-day rules: hold losartan and empagliflozin on days of vomiting, diarrhea or not eating, and restart after a day of normal eating and drinking",
          "Potassium and creatinine two to four weeks after each start or increase, then every six months with the urine albumin; booking the draws on her days at home is acceptable",
          "Amlodipine as the next medicine if blood pressure stays above goal on the maximum losartan dose; no potassium-based salt substitutes",
          "Hepatitis B, hepatitis C and HIV tests now, as part of the evaluation of new CKD, and hepatitis B vaccination if she is not immune",
          "APOL1 genotyping may be offered with genetic counseling: two high-risk variants raise the lifetime risk of kidney disease and help explain it, but the result would not change today's treatment; it is her choice whether and when to test",
          "No biopsy now; reconsider for hematuria, albuminuria rising above 1,000 mg/g despite treatment, or an unexplained fall in eGFR of more than 30%",
          "Avoid NSAIDs, and tell any clinician about her kidneys before contrast dye"
        ],
        "communication": "Discussed with Dr. Okonjo-Bell after the visit. The diagnosis, the low 5-year risk and each medicine were explained to Madam Walker with the numbers, and she agreed to start losartan and empagliflozin today. APOL1 testing was explained and written information given; she will decide later",
        "follow_up": "Nephrology review in about six months, by video if she prefers, or sooner for potassium above 5.5 mmol/L, a fall in eGFR of more than 30%, albuminuria rising, or blood pressure not at goal on three medicines; Dr. Okonjo-Bell continues care and monitoring"
      },
      "guideline_ids": [
        "GL-KDIGO-CKD-2024",
        "GL-KDIGO-BP-2021",
        "GL-AHA-HTN-2025",
        "GL-CKDEPI-2021",
        "GL-NKF-ASN-2021"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "She wants to keep building her company and keep traveling to her agents, and does not want to be told to slow down",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to her documented pace of work.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She is worried that her kidneys could fail and wants to know plainly what the numbers mean",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She wants a plan that works on the road: medicines, readings, food and tests",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Blood pressure below 130/80 mmHg in the clinic and at home within six months, lower toward a systolic of 120 if well tolerated",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "122/76 in the clinic; home average 123/77 on losartan 100 mg and amlodipine 5 mg",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Urine albumin-to-creatinine ratio lower by at least 30% within six months",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "286 to 294 mg/g at baseline; 128 mg/g at six months, 56% lower",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Kidney function stable, without a fall in eGFR of more than 30% after starting treatment",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "eGFR 54 to 55 at baseline; 50 to 51 on treatment, a dip of under 10%",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Sodium under 2 g a day using foods she likes, at home and on the road",
        "status": "active",
        "target_date": "2026-08-17",
        "outcome": "Salt-free seasoning at home and ordering strategies on the road; restaurant meals still the hardest part",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diet goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "LDL cholesterol lower by at least 30%",
        "status": "completed",
        "target_date": "2026-04-27",
        "outcome": "174 to 98 mg/dL on atorvastatin 20 mg, 44% lower",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Care that fits her work: every check scheduled around her travel, by her choice",
        "status": "completed",
        "target_date": "2026-08-17",
        "outcome": "Laboratory checks booked before trips are planned after two missed checks; video visits between trips",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic access goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Nephrology consultation at the two-week visit for albuminuria and a reduced eGFR found at 49: the likely cause, whether more tests or a biopsy are needed, kidney-protective treatment, APOL1 testing, and monitoring that fits her travel",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic specialist referral.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Confirm the diagnosis outside the office: 24-hour ambulatory monitoring on a day at home, and a validated upper-arm home monitor with a correctly sized cuff that travels with her, two readings morning and evening for seven days, travel days included; recheck in two weeks",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic blood pressure plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Kidney evaluation: repeat urine albumin and creatinine at two weeks, compared with last year's results to establish chronicity; urinalysis; kidney ultrasound; calcium, phosphate, parathyroid hormone and 25-hydroxyvitamin D at baseline; every eGFR reported by the race-free CKD-EPI 2021 equation; no ibuprofen or naproxen",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-NKF-ASN-2021",
          "GL-CKDEPI-2021",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic kidney evaluation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Heart and vascular risk: ECG at intake and an echocardiogram for the left ventricular hypertrophy it shows; a fundus examination; TSH and A1c at diagnosis; lipid panel and 10-year ASCVD risk by the Pooled Cohort Equations",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-ACC-CHOL-2018",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic cardiovascular evaluation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Food: sodium under 2 g a day built on what she eats, not a new diet: a salt-free seasoning blend for the dishes she cooks on Sundays, smoked turkey in small amounts in place of salt pork, ordering strategies for banquets and restaurants, water instead of a third coffee on travel days; video sessions with a registered dietitian between trips; no potassium-based salt substitutes until her kidney tests and any new medicines are settled",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-KDIGO-CKD-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diet plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Work and rest on her terms: she sets her schedule; the risks of uncontrolled blood pressure and kidney disease are stated plainly and any medicines are chosen to do the work, timed to her home clock across time zones, with a written sick-day card for her bag; a protected sleep window on travel nights and walking during layovers; video visits between trips and laboratory checks on her days at home",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-KDIGO-CKD-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic work and self-management plan, the teaching contrast with the historical advice to slow down.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Mood and stress: PHQ-9 at intake and yearly",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mood plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-008",
        "display": "Vaccines: influenza today; pneumococcal, hepatitis B and Tdap needs reviewed at the preventive visit; influenza and COVID-19 each autumn",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-IMZ-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        }
      },
      {
        "id": "INT-009",
        "display": "Gastroenteritis: oral rehydration, ondansetron as needed, losartan and empagliflozin held until she has eaten and drunk normally for 24 hours, then restarted; a metabolic panel within a week",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan decided at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "recorded_date": "2026-04-13"
      },
      {
        "id": "INT-010",
        "display": "As the nephrologist advised: losartan 50 mg, increased to 100 mg at two weeks if potassium and creatinine allow; empagliflozin 10 mg daily; sick-day rules for both; potassium and creatinine two to four weeks after each start or increase, accepting a creatinine rise of up to 30%; urine albumin at about three months, then every six months; blood pressure goal below 130/80, lower toward a systolic of 120 if well tolerated, with amlodipine as the next medicine",
        "status": "completed",
        "guideline_ids": [
          "GL-KDIGO-CKD-2024",
          "GL-KDIGO-BP-2021",
          "GL-AHA-HTN-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan decided at the two-week visit with the nephrologist.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "recorded_date": "2026-02-23"
      },
      {
        "id": "INT-011",
        "display": "Atorvastatin 20 mg daily, chosen with her after reviewing her 10-year ASCVD risk of 7.9% with CKD as a risk enhancer; lipid panel and ALT at four to twelve weeks",
        "status": "completed",
        "guideline_ids": [
          "GL-ACC-CHOL-2018",
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic shared decision at the two-week visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "recorded_date": "2026-02-23"
      },
      {
        "id": "INT-012",
        "display": "Amlodipine 5 mg added for home readings above goal on losartan 100 mg; every laboratory check booked on a home day before her trips are scheduled, by her office, after two missed checks",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-KDIGO-CKD-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic medicine change and corrective step decided at the eleven-week review.",
          "author": "The Human Record generator",
          "created": "2026-11-04T20:00:00-05:00"
        },
        "recorded_date": "2026-04-27"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-AHA-HTN-2025",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults",
        "publisher": "American Heart Association and American College of Cardiology (J Am Coll Cardiol 2025)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40815242/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-KDIGO-CKD-2024",
        "title": "KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney International)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38490803/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-KDIGO-BP-2021",
        "title": "KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease",
        "publisher": "Kidney Disease: Improving Global Outcomes (Kidney International)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33637192/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-CKDEPI-2021",
        "title": "New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race",
        "publisher": "Inker LA et al., N Engl J Med 2021",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34554658/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-NKF-ASN-2021",
        "title": "A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease",
        "publisher": "National Kidney Foundation and American Society of Nephrology (Am J Kidney Dis 2022)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34563581/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ACC-CHOL-2018",
        "title": "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol",
        "publisher": "American College of Cardiology and American Heart Association (Circulation 2019)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/30586774/",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, hyperlipidemia and depression monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-BRCA-2024",
        "title": "Breast Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-HBV-2023",
        "title": "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recomm Rep 2023)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36893044/",
        "version_or_year": "2023"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the confirmation of hypertension by ambulatory monitoring, the CKD G3a A2 staging with the race-free eGFR and prior results for chronicity, losartan titration and the creatinine and potassium checks, empagliflozin without diabetes, the statin chosen at intermediate risk, the sick-day handling during gastroenteritis, and the APOL1 discussion."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: the Indiana Historical Society, 64 Parishes, the National Archives, the National Women's History Museum, the Gale Women in World History entry, the Lemelson Center, A'Lelia Bundles's site, and a passage of her biography quoted in Wikipedia. The NMAAHC pages, the New York Times obituary and the biography itself could not be read."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health claim is made; the mood screen is synthetic and below the threshold for a safety assessment. Her history is told with attention to slavery, poverty and the forms of address she refused, without stereotype; her work is treated as hers to direct."
    }
  }
}
